Symbiomix

Symbiomix Therapeutics is a biopharmaceutical company bringing innovative medicines to market for prevalent gynecological infections than can have serious health consequences. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world’s leading healthcare venture capital firms: OrbiMed, F-Prime Capital Partners, and HBM Partners. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
ADVERTISEMENT

Stomach Pain. Diarrhea. Nausea. Could It Be Crohn’s or Ulcerative Colitis?

Our new IBD education program will help you understand your symptoms and better manage your condition

Programs

Taking Control of My Crohn's Disease

How cultural stigma impacted my journey with IBD

Created With Support

Fast Facts: What You Need to Know About Inflammatory Bowel Disease

Learn about the symptoms, how it's diagnosed and how to manage your care

Created With Support